JMP Securities Sticks to Their Buy Rating for Cytokinetics (CYTK)
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.
JMP Securities Reaffirms Their Buy Rating on Haemonetics (HAE)
In a report released today, David Turkaly from JMP Securities maintained a Buy rating on Haemonetics (HAE – Research Report), with a price ...
Affirm stock price target raised to $85 at JMP Securities
JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...
JMP Securities maintains Sprinklr stock with $17 target
JMP Securities reiterated a Market Outperform rating on Sprinklr Inc (NYSE:CXM), with a steady price target of $17.00. The firm's analysts highlighted the company's current performance, which includes ...
Stock Traders Purchase High Volume of Mr. Cooper Group Call Options (NASDAQ:COOP)
Mr. Cooper Group Inc. (NASDAQ:COOP – Get Free Report) was the target of unusually large options trading on Wednesday. Traders acquired 10,613 call options on the stock. This is an increase of ...
Business Wire1h
Bally’s Corporation Completes Transactions With Standard General and The Queen Casino & Entertainment
Bally’s Corporation (NYSE: BALY; BALY.T) (“Bally’s” or the “Company”) today announced that it has completed the previously ...
Roku, Inc. (ROKU): Among Cathie Wood’s Top Stock Picks for 2025
Roku Inc. (NASDAQ:ROKU) posted excellent fiscal third-quarter 2024 results, exceeding $1 billion in total net sales for the ...